HealthStream Inc (HSTM) is a publicly traded Healthcare sector company. As of May 21, 2026, HSTM trades at $23.88 with a market cap of $694.15M and a P/E ratio of 36.26. HSTM moved -2.03% today. Year to date, HSTM is +3.86%; over the trailing twelve months it is -16.51%. Its 52-week range spans $19.50 to $34.24. Analyst consensus is buy with an average price target of $32.00. Rallies surfaces HSTM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
HealthStream Reports 7.4% Q4 Revenue Growth, Canaccord Cuts Target to $21: Canaccord cut HealthStream’s price target from $25 to $21 while maintaining a Hold rating, citing Q4 revenue of $79.7M (7.4% increase) and EBITDA of $18.8M (16.4% gain). Full-year revenue rose 4.3% to $304.1M, EBITDA climbed 7.5% to $71.8M, shares repurchased totaled $10M and the dividend rose to $0.035.
| Metric | Value |
|---|---|
| Price | $23.88 |
| Market Cap | $694.15M |
| P/E Ratio | 36.26 |
| EPS | $0.67 |
| Dividend Yield | 0.04% |
| 52-Week High | $34.24 |
| 52-Week Low | $19.50 |
| Volume | 16 |
| Avg Volume | 0 |
| Revenue (TTM) | $311.78M |
| Net Income | $19.92M |
| Gross Margin | 0.00% |
4 analysts cover HSTM: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $32.00.